The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

Exo-S3 lineup brings AI-powered, lightweight leg assistance to the market LAS VEGAS, Jan. 3, 2026 /PRNewswire/ -- Today at CES 2026, Sumbu announced its Exo-S3 line of dual-vector exoskeletons ...

MILAN, November 21, 2025--(BUSINESS WIRE)--On the heels of AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking ...

Physician-researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States with its National Medical Center named Top 5 in the nation for cancer by U ...